Try our Advanced Search for more refined results
In Re Vitamin C Antitrust Litigation
Case Number:
1:06-md-01738
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Amamgbo & Associates
- Baker McKenzie
- BoiesBattin
- Boies Schiller
- Cadwalader Wickersham
- Cohen Milstein
- Gibbs & Bruns
- Glancy Prongay
- Greenberg Traurig
- Gustafson Gluek
- Hausfeld LLP
- Hofheimer Gartlir
- Houser LLP
- Izower Feldman
- Johns Flaherty
- Joseph Saveri Law Firm
- Kirby McInerney
- Kobre & Kim
- Lieff Cabraser
- Massey & Gail
- Morris Laing
- Moscone Emblidge
- Orrick Herrington
- Paul Weiss
- Saveri & Saveri
- Seward & Kissel
- Sidley Austin
- Slinde Nelson
- Susman Godfrey
- Wilson Sonsini
- Zelle LLP
-
April 02, 2013
Chinese Co. Northeast Settles Vitamin C Antitrust Claims
Northeast Pharmaceutical Group Co. Ltd. filed a settlement Monday with indirect purchasers in multidistrict antitrust litigation over alleged price-fixing by vitamin C producers, ending the Chinese company's involvement in the sprawling New York case.
-
March 25, 2013
Chinese Vitamin Cos. To Pay $23M To Settle Price-Fixing Plot
Weisheng Pharmaceutical Company Ltd. and its parent, China Pharmaceutical Group Ltd., agreed to pay $22.5 million and comply with any injunction issued against any co-defendant to settle price-fixing claims for vitamin C after dropping out of a class-action trial in New York federal court that walloped their co-defendants with a $54.1 million penalty.
-
March 14, 2013
Jury Finds Chinese Vitamin C Makers Fixed Prices
A New York federal jury returned a $54.1 million verdict Thursday against North China Pharmaceutical Group Corp. and its vitamin C manufacturing unit for illegal collusion, rejecting their defense that the Chinese government forced them to fix prices and limit supply to a class of U.S. businesses.
-
March 13, 2013
Vitamin C Price-Fix Suit Loses 2 Defendants Before Jury Ruling
A New York federal judge said Wednesday that China Pharmaceutical Group Ltd. and its vitamin C production unit have bowed out of an antitrust trial alleging Chinese manufacturers fixed prices and limited supply of the nutrient to U.S. purchasers, just hours before the case was sent to a jury.
-
March 11, 2013
Blaming Vitamin C Price Hike On SARS Absurd, Jury Hears
A report commissioned by Chinese vitamin C manufacturers attributing sharp price increases to fears over SARS and avian flu outbreak — as opposed to industry collusion — is "nonsensical" and riddled with mathematical errors, a Stanford University economics professor testified Monday in a multidistrict litigation before a New York federal jury.
-
March 07, 2013
China Ordered Vitamin C Price-Fixing, Jury Hears
A former government official from China on Thursday doubled down on his assertion that vitamin C manufacturers were required to fix prices as part of the Ministry of Commerce's coordination of the industry, a day after a Brooklyn federal jury was shown evidence appearing to undercut that notion.
-
March 06, 2013
Ex-Official Backtracks On China's Role In Vitamin C Price-Fixing
An ex-Chinese-government official testifying in defense of vitamin C manufacturers once told the Ministry of Commerce he had doubts about his power to enforce rules that forced the industry to fix prices, contradicting previous testimony, a jury heard Wednesday in New York federal court.
-
March 05, 2013
Chinese Vitamin C Collusion Was Coerced, Ex-Official Says
Chinese vitamin C makers were forced to fix prices or risked being banned from the lucrative U.S. market by the Chinese government, a former official from the country's Ministry of Commerce told a jury Tuesday.
-
March 04, 2013
Chinese Vitamin C Makers Fabricated Export Docs, Jury Told
China Pharmaceutical Group Ltd.'s executive director agreed Monday that vitamin C manufacturers fabricated customs documents to get around a government-mandated price floor, starting the second week of a trial over an alleged price-fixing conspiracy among Chinese vitamin C makers.
-
February 27, 2013
China Influenced Vitamin C Cos.' Price-Fixing, Jury Told
Chinese trade regulators could impose penalties against vitamin C manufacturers, including blocking them from selling to foreign customers, if they refused to participate in an industry group that allegedly forced them to fix prices and limit supply, a New York federal jury heard Wednesday.